Monosaccaridi

Nicotine-N-b-D-glucuronide hydrate is a metabolite of nicotine that is excreted in the urine as an organic anion. It has been shown to have anticancer activity against a variety of human cancer cell lines, including lung, stomach, colon, and prostate. Nicotine-N-b-D-glucuronide hydrate has also been shown to inhibit protein synthesis in vitro by interfering with the ability of cells to import amino acids such as tryptophan and phenylalanine. The same study also showed that this metabolite can cause symptoms similar to those caused by nicotine withdrawal.

(R)-Naproxen acyl-b-D-glucuronide benzyl ester is a custom-synthesized molecule. The synthesis of this compound is accomplished by the modification of naproxen, which is a commercially available drug. The fluorination and methylation steps are accomplished to provide a more potent drug. This compound exhibits anti-inflammatory properties that may be due to its inhibition of prostaglandin synthesis.

2-Hydroxyimipramine b-D-glucuronide is a custom synthesis, modification, and fluorination of the drug 2-hydroxyimipramine. The methyl group from the molecule is replaced with a fluoro group. This modification leads to a new compound with improved pharmacokinetic properties. The new compound also has glycosylation sites on the sugar ring that are not present in the parent drug. This modification may lead to an increase in the therapeutic efficacy of 2-hydroxyimipramine b-D-glucuronide as it interacts with other drugs and increases their bioavailability.

D-Allose is a sugar that is modified with a fluorine atom at position 6. This modification can be used to trace the origin of D-allose in complex carbohydrates such as glycogen and glycosylated proteins. The addition of a 13C6 atom allows for the identification of this sugar through mass spectrometry and nuclear magnetic resonance (NMR) analysis.

b-Core-APE-HSA is a custom synthesis of an oligosaccharide. This product is a complex carbohydrate with a CAS number and the molecular weight range of 500 to 10,000 Daltons. It is a polysaccharide that has been modified by methylation or glycosylation. The saccharide in this product is either glucose or mannose and it can be modified using click chemistry, fluorination, or other modifications. This product has high purity and can be synthesized using synthetic techniques such as glycosylation or Methylation.

1,2,3,4-Tetra-O-acetyl-L-xylopyranose is a custom synthesis product. It is a sugar that is found in glycosaminoglycans and proteoglycans. This product can be customized through the modification of the sugar with fluorination, methylation, acetylation or other modifications. This product has a CAS number of 142130-89-0 and can be synthesized from sucrose using Click chemistry. The chemical name for this compound is 1,2,3,4-Tetra-O-[(trimethylsilyl)acetyl]-L-xylopyranose.

D-Ribopyranosyl thiosemicarbazide is a glycosylation agent that can be used in the synthesis of complex carbohydrates. It also has the ability to modify sugar structures, such as methylation, click modification, and fluorination. This reagent can be used for the modification of saccharides, oligosaccharides, and monosaccharides. D-Ribopyranosyl thiosemicarbazide is synthesized from d-ribose and thiosemicarbazide. The CAS number for this product is 95352-77-5.

PBS 57 is a pluripotent cell-derived protein that has been shown to be a potent vaccine adjuvant. PBS 57 is derived from the plasma of pregnant women and contains the following antigenic determinants: glucose, human albumin, and human immunoglobulin G. PBS 57 can stimulate both humoral and cellular immunity in mice with deficiencies in antibody production or T cells. PBS 57 has also been shown to have strong pro-inflammatory cytokine activity, which may be due to its ability to induce galacturonic acid release from macrophages.

Anthracycline antibiotic with potent anti-tumoral activity. The compound interferes with DNA replication and RNA transcription since it intercalates between the base pairs of nucleic acids. It also inhibits the topoisomerase II, proteasome and generates free radicals, which leads to cell death of treated cells. Moreover, daunorubicin triggers apoptosis trough the stimulation of ceramide synthesis. It has been used as chemotherapy agent for the treatment of myeloid leukaemia (AML) and acute lymphocytic leukaemia (ALL).